Why is Godavari Drugs Ltd ?
1
Weak Long Term Fundamental Strength with a -5.64% CAGR growth in Net Sales over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.56 times
2
Flat results in Sep 26
- EPS(Q) Lowest at Rs 0.88
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Godavari Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Godavari Drugs
45.98%
0.70
65.51%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
-5.64%
EBIT Growth (5y)
-2.93%
EBIT to Interest (avg)
2.21
Debt to EBITDA (avg)
4.31
Net Debt to Equity (avg)
1.00
Sales to Capital Employed (avg)
1.82
Tax Ratio
18.42%
Dividend Payout Ratio
0
Pledged Shares
0.18%
Institutional Holding
2.59%
ROCE (avg)
12.08%
ROE (avg)
10.66%
Valuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
40
Price to Book Value
1.67
EV to EBIT
25.03
EV to EBITDA
19.38
EV to Capital Employed
1.33
EV to Sales
1.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.33%
ROE (Latest)
4.95%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
EPS(Q)
Lowest at Rs 0.88
Loading Valuation Snapshot...
Here's what is not working for Godavari Drugs
Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.88
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)